Devin Wenig, Director at NASTECH PHARMACEUTICAL CO INC (NSTK), sold 3,000 shares at $18.60 ($55K) on 2006-12-01, disclosed to the SEC on 2006-12-01.
Scheduled sale ($55k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.21 | 200 | $4K | 6.6% |
| 2 | $18.22 | 400 | $7K | 13.2% |
| 3 | $18.23 | 200 | $4K | 6.6% |
| 4 | $18.28 | 400 | $7K | 13.3% |
| 5 | $18.30 | 400 | $7K | 13.3% |
| 6 | $18.31 | 200 |
| $4K |
| 6.6% |
| 7 | $18.40 | 100 | $2K | 3.3% |
| 8 | $18.44 | 200 | $4K | 6.7% |
| 9 | $18.50 | 387 | $7K | 13.0% |
| 10 | $18.51 | 213 | $4K | 7.2% |
| 11 | $18.60 | 300 | $6K | 10.1% |
| Total | $18.36 avg | 3,000 | $55K | 100% |
| Filing → |
| EBAY | SELL | 2019-07-03 | $398K | — | Filing → |
| EBAY | SELL | 2018-02-08 | $11.5M | — | Filing → |
| EBAY | SELL | 2013-10-31 | $2.4M | — | Filing → |